Viking Therapeutics, Inc. (VKTX) is listed on NASDAQ in Pharmaceutical Stocks. It is $32.15, -5.05%, with a $3.8B market cap. RSI is 38.6, near oversold. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 38.6 Near Oversold
Market Cap $3.8B
Volume 1.4M
Fundamentals — 10-Q Q2 2026
Revenue $0
Net Income $-286.3M
EPS $-2.47
P/E Ratio -13.0x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Lian Brian | President & CEO | Sell | 148,517 | $33.32 | $4.9M | 2026 Jul 29 |
| Zante Greg | Chief Financial Officer | Sell | 21,217 | $33.47 | $710,141 | 2026 Jul 29 |
| Mancini Marianna | Chief Operating Officer | Sell | 18,217 | $33.47 | $609,636 | 2026 Jul 29 |
| Aubuchon Neil William | Chief Commercial Officer | Buy | 4,475 | $33.50 | $149,913 | 2026 Mar 10 |
| Mancini Marianna | Chief Operating Officer | Sell | 6,185 | $35.00 | $216,475 | 2025 Oct 28 |
| Lian Brian | President & CEO | Sell | 38,989 | $35.01 | $1.4M | 2025 Oct 28 |
| Zante Greg | Chief Financial Officer | Sell | 6,185 | $35.00 | $216,475 | 2025 Oct 28 |
| Rowland Charles A Jr | Director | Sell | 60,000 | $35.57 | $2.1M | 2025 Oct 27 |
| Zante Greg | Chief Financial Officer | Sell | 4,266 | $27.76 | $118,424 | 2025 Jul 3 |
| Mancini Marianna | Chief Operating Officer | Sell | 4,266 | $27.77 | $118,467 | 2025 Jul 3 |
| Lian Brian | President & CEO | Sell | 26,889 | $27.80 | $747,514 | 2025 Jul 3 |
| Rouan Sarah Kathryn | Director | Buy | 1,240 | $24.15 | $29,946 | 2025 Mar 31 |
| Mancini Marianna | Chief Operating Officer | Sell | 54,215 | $42.75 | $2.3M | 2025 Jan 6 |
| Lian Brian | President & CEO | Sell | 194,490 | $42.74 | $8.3M | 2025 Jan 6 |
| Zante Greg | Chief Financial Officer | Sell | 50,309 | $42.75 | $2.2M | 2025 Jan 6 |
| Macartney Lawson | Director | Sell | 2,000 | $68.67 | $137,340 | 2024 Nov 8 |
| Zante Greg | Chief Financial Officer | Sell | 131,687 | $76.62 | $10.1M | 2024 Oct 28 |
| Rouan Sarah Kathryn | Director | Sell | 11,000 | $80.89 | $889,790 | 2024 Oct 25 |
| Singleton J Matthew | Director | Sell | 16,000 | $79.50 | $1.3M | 2024 Oct 25 |
| Lian Brian | President & CEO | Sell | 216,130 | $70.83 | $15.3M | 2024 Sep 20 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $34.78 | 68.0 | $3.9B |
| | $84.95 | 54.8 | $12.0B |
| | $13.71 | 51.0 | $10.9B |
| | $113.77 | 55.4 | $12.3B |
| | $53.91 | 53.0 | $8.3B |
Take VKTX further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put VKTX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Viking Therapeutics, Inc. next reports.
Set alerts on VKTX
Get notified when Viking Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free